US Stocks
/
Harrow, Inc. Share Price
Harrow, Inc. Share Price

Harrow, Inc. Share Price

NASDAQ: HROW | Small Cap
$29.36
-$1.23 (-4.04%) Last updated on 10 Oct, 2026 | 01:29 IST
  • Performance
  • Chart
  • Fundamentals
  • Quarterly P&L
  • Annual P&L
  • About
  • Price history
  • FAQs

Harrow, Inc. Stock Performance

Open
$30.53
Prev. Close
$30.59
Circuit Range
N/A
Day Range
$27.02 - $30.53
Year Range
$27.02 - $54.77
Volume
56,856
Average Traded
$28.78

Harrow, Inc. Share Price Today

As of 11 October 2026, Harrow, Inc.'s share price is $29.36. The stock opened at $30.53, compared to its previous close of $30.59. During today's trading session, Harrow, Inc.'s share price traded between $27.02 and $30.53, with an average price of $28.77. Over the past 52 weeks, the stock has recorded a high of $54.77 and a low of $27.02. In terms of performance, Harrow, Inc.'s share price has declined by 27.64% over the last six months and is down 22.30% on a year-on-year basis.

Harrow, Inc. Share Price Chart

$27.02$30.53
L
Show Current Price
H

Harrow, Inc. Stock Fundamentals & Key Indicators

Market Cap
$1.08B
PE Ratio (TTM)
N/A
Dividend Yield
0.00%
EPS (TTM)
$-0.99
Revenue (TTM)
$272.30B
Return On Equity (TTM)
-244.91%
Profit Margin
-1.89%
Debt to Equity
19.24
Quarterly Earnings Growth YoY
-1793.14%

Harrow, Inc. Quarterly Profit & Loss

All figures in USD

ParticularsSep 2025Dec 2025Mar 2026Jun 2026
Revenue$71.64$89.09$44.20$70.66
Net Profit$1.02$6.63-$27.60-$17.27
Net Profit Margin1.42%7.44%-62.44%-24.44%
Income ChangeN/A550.00%-516.29%37.43%

Harrow, Inc. Annual Profit & Loss

All figures in USD

Particulars2022202320242025
Revenue$88.60$130.19$199.61$272.30
Net Profit-$14.09-$24.41-$17.48-$5.14
Net Profit Margin-15.90%-18.75%-8.76%-1.89%
Income ChangeN/A-73.24%28.39%70.59%

About Harrow, Inc.

Harrow Inc is an eyecare pharmaceutical company engaged in the discovery, development, and commercialization of ophthalmic pharmaceutical products for the U.S. market. The company partners with U.S. eyecare professionals to develop products used to manage ophthalmic conditions affecting both the front and back of the eye, such as dry eye disease, cataracts, refractive errors, glaucoma, etc. Its portfolio of branded ophthalmic pharmaceuticals includes Iheezo, Vevye, Byooviz Opuviz, Natacyn, Maxitrol, Maxidex, etc. Additionally, the company's development pipeline comprises candidates like MELT-300, H-N08, CR-01, and MELT-210, being developed to address unmet needs in eye care and selected adjacent markets. Its reportable segments are: Branded, which derives maximum revenue, and ImprimisRx.

Harrow, Inc. Historical Returns

MonthOpenCloseChange %
Oct 2026
$30.76
$29.34
-4.80%
Sep 2026
$36.95
$30.82
-19.97%
Aug 2026
$38.40
$38.51
-0.44%
Jul 2026
$43.17
$38.68
-8.95%
Jun 2026
$34.95
$42.48
+20.66%
May 2026
$40.58
$35.20
-13.22%
Apr 2026
$36.16
$40.57
+14.93%
Mar 2026
$53.44
$35.30
-34.94%
Feb 2026
$44.36
$54.26
+32.82%
Jan 2026
$48.91
$40.85
-16.62%
Dec 2025
$40.28
$48.99
+17.45%
Nov 2025
$37.21
$41.71
+10.40%

HROW Share Price FAQs

What is Harrow, Inc. share price today?

chevron-up
Harrow, Inc. share price today is $29.36 as on October 10, 2026 at 1:29 am IST.

What is the 52 week high and 52 week low of Harrow, Inc. stock?

chevron-up
The 52 week high of Harrow, Inc. stock is $54.77, while the 52 week low is $27.02 as of 10 Oct '26.

What is HROW's market capitalisation today?

chevron-up
HROW market capitalisation is $1.08B as of October 11, 2026, at 4:01 pm IST.

What is HROW's net income for the last quarter?

chevron-up
HROW's net income for the last quarter is -17.27B USD.

What is the 5 year returns of HROW?

chevron-up
The 5 year returns of HROW is 190.93% as on 10 Oct '26.

What is the high & low stock price of HROW today?

chevron-up
HROW stock price hit a high of $30.53 and low of $27.02 as of 10 Oct '26.

Can I buy HROW shares in India?

chevron-up
Yes. You can buy HROW in India by opening an international trading account.